Showing results (321-330 of 1,091) with videos related to

Sort By:
Pageof 110
Journal of Thrombosis and Haemostasis : JTH|June 28, 2013
Inhibitor development in previously treated hemophilia A patients: a systematic review, meta-analysis, and meta-regressionM Xi, M Makris, M Marcucci, et al.
Thrombosis and Haemostasis|February 28, 1986
Fibrinogen Milano II: a congenital dysfibrinogenaemia associated with juvenile arterial and venous thrombosisF Haverkate, J Koopman, C Kluft, et al.
International Journal of Clinical & Laboratory Research|January 1, 1994
Prognostic value of the activated partial thromboplastin time after orthotopic liver transplantation. A prospective studyI Martinelli, M Moia, B Gridelli, et al.
Thrombosis and Haemostasis|February 28, 1986
High plasma levels of protein C activity and antigen in the nephrotic syndromeP M Mannucci, C Valsecchi, B Bottasso, et al.
Blood|December 1, 1992
Identification of a new congenital defect of platelet function characterized by severe impairment of platelet responses to adenosine diphosphateM Cattaneo, A Lecchi, A M Randi, et al.
Thrombosis Research|November 1, 1992
Enzyme-linked immunosorbent assay of human factor VII based upon a monoclonal antibody that recognizes the native conformation of the proteinR Coppola, S Tombesi, F Valentini, et al.
British Journal of Haematology|December 12, 2001
Laboratory control of oral anticoagulant treatment by the INR system in patients with the antiphospholipid syndrome and lupus anticoagulant. Results of a collaborative study involving nine commercial thromboplastinsA Tripodi, V Chantarangkul, M Clerici, et al.
American Journal of Hematology|August 1, 1995
Platelet von Willebrand factor abnormalities in myeloproliferative syndromesG Castaman, A Lattuada, M Ruggeri, et al.
Thrombosis and Haemostasis|November 30, 1990
Subcutaneous desmopressin (DDAVP) shortens the prolonged bleeding time in patients with liver cirrhosisM Cattaneo, P M Tenconi, I Alberca, et al.
Lancet (London, England)|November 28, 1987
Improvement in the haemostatic defect of uraemia after treatment with recombinant human erythropoietinM Moia, P M Mannucci, L Vizzotto, et al.
Pageof 110